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Editorial
Antiretroviral therapy in sub-Saharan Africa: evidence about
need, uptake and impact from community-based cohort studies
Jim Todd, Ally Wringe, Sian Floyd and Basia Zaba
London School of Hygiene and Tropical Medicine, London, UK
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Antiretroviral therapy (ART) has transformed the lives of
individuals with HIV in many parts of sub-Saharan Africa
(UNAIDS 2011). In common with other regions of the
world, after starting ART, people living with HIV have
survived longer, regained their health, and resumed their
economic activities. However, with more than 20 million
people infected with HIV on the African continent,
helping only a proportion of them is not enough. We need
to know how ART is affecting the HIV epidemic at the
population level: how many HIV positive people need ART
according to current WHO guidelines, how many are
taking ART and how many lives have been saved. National
statistics on the numbers of people receiving ART or on the
number of drugs delivered do not tell us whether access is
equitable or what the overall impact is on the population.
The data used in this supplement to Tropical Medicine
and International Health come from population-based
cohorts where HIV status has been measured over many
years and from the analysis of demographic and health
surveys (DHS). Longitudinal cohort studies that include
data on HIV infection are a valuable resource to help us
understand the impact of the epidemic in the community
(Maher et al. 2010). They also enable us to see, at
population-level, how well we are doing in our efforts to
care for and treat HIV-infected people and their families.
This collection of papers provides important evidence on
the ways we can improve access to HIV Counselling
and Testing (HCT) and uptake of ART. This will add to
the information that has already been assembled by the
ALPHA network on the prevalence and incidence of HIV
in these communities, as well as on individual-level
mortality and the impact of HIV on families living in these
communities (Hosegood et al. 2007; Todd et al. 2007).
As the first step, Zaba et al. (2012) present a newmethod
for estimating the need for ART. Based on earlier studies by
the ALPHA network sites onmortality amongHIV-infected
individuals, this approach simplifies the calculations for
estimating the population-level need for ART. The method
can be applied to any population in which the age-specific
prevalence of HIV is known.While it does not allow the
identification of individuals in need of ART, it does allow
national, district and community level planners topredict the
overall need for ART over several years. This method has
many advantages, but before it can be used more widely, it
needstobeappliedincohortstudiestoestablishitscredibility.
Uptake of HCT is the next step considered. The paper by
Isingo et al. (2012) analyses trends in HCT in Northern
Tanzania, where HIV surveillance in combination with
mobile clinics offering HCT has boosted the numbers who
know their HIV status. Cremin et al. (2012) analysed DHS
data on trends in self-reported testing for HIV, which
include all types of HIV testing. These papers show gradual
increases in the proportion who have ever tested for HIV
over time, with the highest proportion in those with more
education, and in those who are HIV positive; this
probably reflects knowledge of ART and its impact on
those living with HIV. The paper by Wringe et al. (2012)
shows how different testing strategies for HIV affect the
numbers that know their status. This has implications for
HIV testing programmes that are trying to ensure that
everyone in the population knows their HIV status.
Uptake of ART is the important step that transforms the
lives of those living with HIV. Two papers, from Tanzania
and Uganda, describe the factors that are associated with
uptake of ART in the population.Wringe et al. (2012) show
how the numbers who obtain ART build up slowlywhen the
service is only available in a referral hospital many miles
away. Incontrast,Kazoobaet al. (2012) reveal thebenefitsof
a single local clinic that can takepatients throughall the steps
from testing and counselling to the provision of ART, with
more than 66%of those in need of ART receiving it in 2008.
The impact of ART can be measured in several ways,
but one of the most important is the effect on all-cause
mortality.With the rising uptake of ART since public-sector
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provision began in 2004, and longer survival of those
starting and remaining on ART, four papers show its
population-level impact on mortality in the community. We
present evidence from Tanzania, Uganda and Malawi
(Marston et al. 2012; Kasamba et al. 2012; Chihana et al.
2012). Floyd et al. (2012) compile the evidence from these
three settings with data from the Africa Centre DSS in South
Africa to show large population-level reductions inmortality
when ART provision has been localised and/or decentral-
ised. This reinforces the anecdotal evidence from these
communities, where carpenters no longer only make coffins
for the dying, but can resumemaking furniture for the living.
The impact of ART can also be seen in the incidence of
orphanhood in the communities, as shown in the paper by
Makumbi et al. (2012), which reminds us that survival of a
parent has wide implications for the whole family.
The final paper in the supplement, by Bernighausen et al.
(2012), points at an important new direction that com-
munity surveillance studies should be taking. By linking
community data with data from clinics, it is possible to get
a more accurate picture of the uptake and continuity of
service use, not only HCT and ART but also family
planning, antenatal clinics and other treatment services.
This article shows that new technology and software can
be used to enable these links.
The overall message from these papers is that we have
progressed a long way since antiretroviral therapy first
became available in sub-Saharan countries in 2004. How-
ever, major discrepancies remain in access to, and uptake
of, ART. Obtaining reliable data on access, uptake and the
population-level impact of ART is difficult, and commu-
nity-based studies such as those that have contributed to
this supplement, are a very valuable resource. Going
forward, we will need to use new technologies to get as full
as possible a picture of how to ensure that these services
reach the people who need them.
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